QuidelOrtho (QDEL) Share-based Compensation (2021 - 2026)
QuidelOrtho (QDEL) reported Share-based Compensation of $1.1 million for Q1 2026, down 21.43% on a YoY basis from $1.4 million in Q1 2025, and down 76.09% sequentially from $4.6 million in Q4 2025.
QuidelOrtho (QDEL) Share-based Compensation (2021 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 6 years of Share-based Compensation data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 21.43% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 264.29% YoY), and the FY2025 full-year result was $5.4 million, up 1700.0% from the prior year.
- Share-based Compensation slipped to $1.1 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $24.2 million in Q3 2024 to a low of -$32.2 million in Q4 2024.
- A 5-year average of $428571.4 and a median of $1.6 million in 2023 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 366.67% in 2025, while the deepest fall reached 113.64% in 2025.
- Tracing QDEL's Share-based Compensation over 5 years: stood at $7.4 million in 2022, then plunged by 243.24% to -$10.6 million in 2023, then sank by 203.77% to -$32.2 million in 2024, then surged by 114.29% to $4.6 million in 2025, then tumbled by 76.09% to $1.1 million in 2026.
- Business Quant data shows QDEL's Share-based Compensation at $1.1 million in Q1 2026, $4.6 million in Q4 2025, and -$3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 1.10 Mn |
| Mar 29, 2026 | 1.10 Mn |
| Dec 28, 2025 | 4.60 Mn |
| Dec 28, 2025 | 4.60 Mn |
| Sep 28, 2025 | -3.30 Mn |
| Sep 28, 2025 | -3.30 Mn |
| Jun 29, 2025 | 2.70 Mn |
| Jun 29, 2025 | 2.70 Mn |
| Mar 30, 2025 | 1.40 Mn |
| Mar 30, 2025 | 1.40 Mn |
| Dec 29, 2024 | -32.20 Mn |
| Dec 29, 2024 | -32.20 Mn |
| Sep 29, 2024 | 24.20 Mn |
| Sep 29, 2024 | 24.20 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Oct 1, 2023 | -10.60 Mn |
| Oct 1, 2023 | -10.60 Mn |